Ciprofloxacin is a fluoroquinolone antibiotic used to treat a number of bacterial infections. It can be taken by mouth, as eye drops, as ear drops, or intravenously.

Alvotech Reveals Encouraging Preliminary Findings from Drug Behavior Analysis of AVT03, a Potential Equivalent to Prolia® and Xgeva®.

Diphenhydramine (DPH) is an antihistamine and sedative mainly used to treat allergies, insomnia, and symptoms of the common cold.

Oricell has received the green light from the FDA for its investigational new drug (IND) application for OriCAR-017, an innovative CAR-T therapy aimed at GPRC5D.

Tamsulosin was approved for medical use in the United States in 1997. Specifically it is an α1 adrenergic receptor blocker.

Sarepta Therapeutics Reveals Encouraging Results from Segment B in the MOMENTUM Phase 2 Trial for SRP-5051, Targeting Exon 51 Skip-Amenable Duchenne Muscular Dystrophy Cases.

Methocarbamol, sold under the brand name Robaxin among others, is a medication used for short-term musculoskeletal pain.

Takeda has disclosed that GAMMAGARD LIQUID®, their intravenous immunoglobulin treatment, has received authorization from the U.S. Food and Drug Administration.

Clindamycin was first made in 1966 from lincomycin and it is of the lincosamide class and works by blocking bacteria from making protein.

Alligator Bioscience Reveals Encouraging Phase 2 Outcomes from OPTIMIZE-1 Study, Succeeding in Main Goal and Showing Significant Survival Advantages for Initial Treatment of Pancreatic Cancer.

Levothyroxine Sodium is a small molecule drug that mimics and targets the thyroid hormone as an agonist.

Vidac Pharma shares encouraging early results from a Phase 2a trial for a rare skin cancer, cutaneous T-cell lymphoma, using its primary drug candidate, VDA-1102.